『Underground USA Daily News Brief』のカバーアート

Underground USA Daily News Brief

Underground USA Daily News Brief

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

 Thursday, July 31st, 2025Whistleblower Alleges Pressure to Support Obama-Era Russia Collusion NarrativeA whistleblower has come forward with claims that their supervisor pressured them to endorse the controversial January 2017 Intelligence Community Assessment (ICA) alleging Russian support for then-candidate Donald Trump, despite concerns over its credibility. According to the account released by Director of National Intelligence Tulsi Gabbard, the whistleblower, a former Deputy National Intelligence Officer, faced threats of denied promotion unless they complied with the narrative, which they believed was directed by the Obama administration. The whistleblower’s attempts to report these concerns to multiple government officials, including the Intelligence Community Inspector General, were reportedly ignored, raising questions about the integrity of the 2016 election-related intelligence processes.Sources: Legal Insurrection, FOX News Nation, National DeskDeclassified Durham Report Annex Implicates Soros in 2016 Trump-Russia NarrativeA newly declassified appendix to Special Counsel John Durham’s 2023 report, released by Senate Judiciary Committee Chairman Chuck Grassley on July 31, 2025, suggests that George Soros’ Open Society Foundations may have been involved in the Hillary Clinton campaign’s efforts to falsely link Donald Trump to Russia during the 2016 election. The document details intercepted communications, including purported emails from Leonard Benardo, a senior official at Soros’ organization, indicating a coordinated plan to “demonize” Trump by tying him to Vladimir Putin, with expectations that the FBI would amplify the narrative. The annex also highlights the FBI’s failure to critically investigate these claims, raising concerns about the politicization of federal agencies. While the authenticity of the emails is deemed likely by Durham’s team, the revelations underscore ongoing debates about transparency and accountability in the 2016 election investigations.Sources: FOX News, Legal Insurrection, Grassley.Senate.govSenate Rejects Trump’s NIH Budget Cuts, Approves $400 Million IncreaseIn a bipartisan move, the Senate Appropriations Committee voted 26-3 to boost the National Institutes of Health (NIH) budget by $400 million for fiscal year 2026, firmly rejecting the Trump administration’s proposed $18 billion cut, which would have slashed NIH funding by 40%. The decision preserves all 27 NIH institutes and centers, dismissing the White House’s consolidation plan and its attempt to alter how the NIH funds universities and research centers. This action underscores Congress’s commitment to maintaining America’s leadership in biomedical research, prioritizing scientific innovation over drastic reductions, though concerns remain about long-term fiscal responsibility and the need for oversight to ensure efficient use of taxpayer dollars.Source: State News, The Hill, Science.orgCongressional Democrats Warn of Investigation if Harvard Settles with Trump AdministrationA group of House and Senate Democrats, many of whom are Harvard alumni, have raised concerns over reports that Harvard University is considering a $500 million settlement with the Trump administration to resolve disputes over alleged civil rights violations and diversity policies. The lawmakers, led by Rep. Sam Liccardo and Sens. Adam Schiff and Chris Van Hollen, argue that such a deal could set a dangerous precedent for political interference in academic institutions. They have threatened a thorough congressional investigation if Harvard proceeds, citing worries about the university yielding to political pressure. This development follows the Trump administration’s broader efforts to challenge elite institutions, which supporters view as holding liberal establishments accountable, while critics see it as overreach.Sources: Boston Globe, NewsMax, Axios, Political WireTrump Demands Big Pharma Slash Drug Prices, Threatens ActionPresident Trump has intensified his push to lower prescription drug costs, sending letters to the CEOs of 17 major pharmaceutical companies, including Eli Lilly, Pfizer, and Merck, demanding they align U.S. prices with lower rates offered in other developed nations within 60 days. Following a May executive order aimed at ending what Trump calls foreign "freeloading" on American innovation, he warned that non-compliance could trigger federal measures, such as tariffs or importing cheaper drugs. The move seeks to address the disparity where Americans pay over three times more for brand-name drugs compared to other OECD countries, despite funding 75% of global pharmaceutical profits. While some companies like AstraZeneca have engaged in discussions, industry experts doubt voluntary compliance, anticipating legal pushback from Big Pharma.Sources: FOX Business, The Australian, Just The NewsSenate Bill Offers Mortgage Relief for Natural Disaster VictimsA new Senate bill, introduced by ...
まだレビューはありません